Clinical Trial Update: Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol [Phase 4]

View source ↗

Summary

A Phase 4 local skin safety study of a topical diclofenac/methyl salicylate/menthol spray has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Irritation

Drugs mentioned

• diclofenac/methyl salicylate/menthol topical spray

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Irritation | Phase 4 | Status: WITHDRAWN